The Change in Temporal Muscle Thickness in Stroke Patients

Bozyaka Training and Research Hospital

Status: Invitation-only

Conditions: Stroke; Sarcopenia

Study type: Observational

Funder types: Other

Identifiers

NCT05456646

BITMS0722

Details and patient eligibility

About

This study aims to evaluate the relationship between sarcopenia and functional outcomes with temporal muscle mass change.

Full description

It is well known that stroke increases the risk of developing sarcopenia . In addition, prestroke sarcopenia is associated with worse functional outcomes in patients with stroke. Temporal muscle thickness (TMT) has recently been proposed as a new marker of whole-body muscle mass and function. Measurement of temporal muscle mass by computed tomography (CT) and magnetic resonance imaging (MRI) has been studied in the literature in recent years. All stroke patients undergo cranial CT or MRI examinations at the time of admission. By evaluating the temporal muscle mass of these patients with these examinations, information about pre-stroke muscle mass and sarcopenia can be obtained. Ultrasonography (USG), on the other hand, may be a more accessible, less expensive, and safer option for assessing muscle mass in the follow-up of stroke patients. This study aims to evaluate the relationship between sarcopenia and functional outcomes with temporal muscle mass change by MRI/CT at admission and by USG in the chronic period.

Enrollment: 150 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of stroke
• Presence of cranial MRI/CT in hospital records

Exclusion criteria

• Medically unstable condition (presence or high risk of impaired consciousness, respiration, or circulation).
• Severe cognitive impairment
• Patients who require intensive care unit.